Ovariectomy selectively reduces the concentration of transforming growth factor beta in rat bone: implications for estrogen deficiency-associated bone loss.
- 15 December 1992
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 89 (24), 12190-12193
- https://doi.org/10.1073/pnas.89.24.12190
Abstract
Previous work showed that production of transforming growth factor beta (TGF-beta) by osteoblast-like rat UMR 106 cells was increased by 17 beta-estradiol at physiological concentrations. To determine whether ovariectomy alters the concentration of TGF-beta in rat long bones, female Sprague-Dawley rats were either sham-operated (n = 19) or ovariectomized (n = 19), pair-fed a semisynthetic diet for 6 weeks, and sacrificed. Tibial and femoral diaphyses were removed and extracted by demineralization. Ovariectomy lowered serum estrogen; did not alter body weight, serum magnesium, or serum 1,25-dihydroxyvitamin D; and produced only modest differences in serum calcium and phosphate concentrations. Hydroxyproline was higher and extractable protein was lower in bones from ovariectomized rats than in bones from sham-operated rats; calcium content did not differ between the two groups of animals. Ovariectomy lowered the concentration of TGF-beta in bone but did not change the concentration of insulin-like growth factors I or II compared with values in bone from control animals. The reduction of bone TGF-beta was evident 6 weeks after surgery but not at 3 weeks. Treatment of ovariectomized rats with estrogen eliminated the TGF-beta deficit. To determine whether 17 beta-estradiol increased TGF-beta production by normal bone cells, mouse osteoblasts were treated for 2 days with 17 beta-estradiol. The production of TGF-beta was increased almost 2-fold by 1 nM 17 beta-estradiol, and short-term treatment stimulated the intracellular accumulation of TGF-beta 1 mRNA. We conclude that ovariectomy reduces deposition of TGF-beta in rat bone and that diminished skeletal TGF-beta could play a role in the pathogenesis of bone loss, fractures, and microfractures that occur in estrogen-deficient states. Our results support the possibility that estrogen and bone TGF-beta may be necessary for normal maintenance of the skeleton in female rats.Keywords
This publication has 50 references indexed in Scilit:
- Rapid publication TGF-β1 induces bone closure of skull defectsJournal of Bone and Mineral Research, 1991
- Insulinlike growth factor II and transforming growth factor β regulate collagen expression in human osteoblastlike cells in vitroJournal of Bone and Mineral Research, 1991
- Stimulation of bone formation in vivo by transforming growth factor-β: Remodeling of woven bone and lack of inhibition by indomethacinBone, 1990
- Quantitation of growth factors IGF-I, SGF/IGF-II, and TGF-β in human dentinJournal of Bone and Mineral Research, 1990
- The comparative effect of ovarian hormone administration on bone mineral status in oophorectomized ratsBone, 1989
- Estradiol stimulates invitro the secretion of insulin-like growth factors by the clonal osteoblastic cell line, UMR106Biochemical and Biophysical Research Communications, 1989
- Growth factors and the regulation of bone remodeling.JCI Insight, 1988
- Hip Fracture and the Use of Estrogens in Postmenopausal WomenNew England Journal of Medicine, 1987
- Isolation of EGF-dependent transforming growth factor (TGFβ-like) activity from culture medium conditioned by fetal rat calvariaeJournal of Bone and Mineral Research, 1987
- Histologic evidence for osteopenia and increased bone turnover in ovariectomized ratsBone, 1986